Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's — Denver, Colorado

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: MTAP-deleted Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma, Advanced Solid Tumors.

Sponsors: Bayer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

• Cancer Centers of Colorado at Saint Joseph Hospital
• Centura Health Porter Adventist Hospital
• University of Colorado Denver Health Sciences
• The Childrens Hospital
• Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
• University of Colorado Denver /ID# 233676
• University of Colorado Cancer Center
• Project Safe, University of Colorado
• National Jewish Health, University of Colorado Denver
• Regents of the University of Colorado
• University of Colorado Cancer Center at UC Health Sciences Center
• Denver Health and Hospitals

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's?

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's conducted?

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has 3 clinical trials on record, with 3 currently active. Their work covers MTAP-deleted Solid Tumors, Advanced/Metastatic Colorectal Adenocarcinoma, Advanced Solid Tumors.

Is Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.